This manufacturing monopoly is one of the root causes of the drug shortage, and relying on China for active ingredients is a national security and public health risk.
Editor's note · Context
Hassan highlights the risks of relying on foreign manufacturing for essential drugs.
Share & report
More from Maggie Hassan
I joined the bill, along with Senators Rick Scott and Marco Rubio, to ensure contracting firms are using taxpayer funds responsibly.
Mr. President, I further ask that the committee-reported substitute amendment be withdrawn; that the Peters substitute amendment, which is at the desk, be considered and agreed to; that the bill, as amended, be considered read a third time…
Mr. President, before I start my remarks, I do want to note that we have had news just now of a terrible tragedy at DCA. There has been a plane crash. We do not know all the details yet, but it is fair to say that, here in DC and all…
I am concerned about the possibility that if the legislation were written in such a way, or if contracting guidelines were scoped in such a way that companies could find loopholes, then that would be disastrous for us.





